FDA warns of heart risks with Trump-promoted malaria drug

Published
0

The US Food and Drug Administration on Friday warned doctors against prescribing a malaria drug touted by President Donald Trump for treating the new coronavirus except in hospitals and research studies, AP reports.

In an alert, regulators flagged reports of sometimes fatal heart side effects among coronavirus patients taking hydroxychloroquine or the related drug chloroquine. The decades-old drugs, also prescribed for lupus and rheumatoid arthritis, can cause a number of side effects, including heart rhythm problems, severely low blood pressure and muscle or nerve damage.

This Monday, April 6, 2020, file photo shows an arrangement of Hydroxychloroquine pills in Las Vegas. At least 13 states have obtained a total of more than 10 million doses of malaria drugs to treat Covid-19 patients despite warnings from doctors that more tests are needed before the medications that President Trump once fiercely promoted should be used to help people with the coronavirus. — AP
This Monday, April 6, 2020, file photo shows an arrangement of Hydroxychloroquine pills in Las Vegas. At least 13 states have obtained a total of more than 10 million doses of malaria drugs to treat Covid-19 patients despite warnings from doctors that more tests are needed before the medications that President Trump once fiercely promoted should be used to help people with the coronavirus. — AP

The warning comes as doctors at a New York hospital published a report that heart rhythm abnormalities developed in most of 84 coronavirus patients treated with hydroxychloroquine and the antibiotic azithromycin, a combo Trump has promoted.

Opinion

Editorial

Yemen offensive
Updated 04 Oct, 2026

Yemen offensive

The best option, therefore, is for Muslim and Arab states to help restore the Saudi-Houthi ceasefire.
Growth transition
04 Oct, 2026

Growth transition

PRIME Minister Shehbaz Sharif’s recent call to move from stabilisation to growth, job creation and export ...
Protection at risk
04 Oct, 2026

Protection at risk

THE recent warning from UNHCR should alarm donor governments. Nearly 8.3m refugees and other forcibly displaced...
Talks, at last
Updated 03 Oct, 2026

Talks, at last

The government’s constant threats to suspend KP’s elected dispensation over a political protest have escalated hostilities considerably. In that context, both sides did well to start talking.
IWT’s future
Updated 03 Oct, 2026

IWT’s future

TOGETHER with the Kashmir dispute, India’s unilateral suspension of the Indus Waters Treaty has become the biggest...
Pained minds
03 Oct, 2026

Pained minds

IN Pakistan, mental healthcare is wedged between two extremes — a luxury or a stigma. Estimates cited by the...